DARU-Journal of Pharmaceutical Sciences

Papers
(The H4-Index of DARU-Journal of Pharmaceutical Sciences is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study48
New psychoactive substances: a multidisciplinary review of challenges and their diverse character29
Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation26
Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater21
Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer20
Effect of vitamins C and E on cancer survival; a systematic review19
Lipid nanoparticles for gene therapy in ocular diseases19
Management and control of intraocular pressure applying macitentan hydrogel film formulation: improved effect of surfactant and cosurfactant system17
Stearyl amine tailored spanlastics embedded within tetronic® nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in v16
Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population16
Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac $$\circledR$$) versus branded tacrolimus (Prograf $$\circledR$$) in de novo liver transplant patients: a randomized clinical 15
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations14
Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis14
Structure based exploration of mitochondrial alpha carbonic anhydrase inhibitors as potential leads for anti-obesity drug development14
Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors14
0.098720073699951